Vimarsana
Biggest News Aggregation in the World

Page 29 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Performance Shares of Evoke Pharma stock opened at $0.63 on Friday. The company has a quick ratio of […]

Source: wkrb13.com
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer's -January 23, 2024 at 09:21 am EST - Vimarsana News

IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer's -January 23, 2024 at 09:21 am EST

Paving the way for a potential Alzheimer’s drug ...

Why IGC Pharma Stock Is Moving Higher - IGC Pharma (AMEX:IGC) - Vimarsana News

Why IGC Pharma Stock Is Moving Higher - IGC Pharma (AMEX:IGC)

IGC Pharma highlighted data from a trial in which the group treated with TGR-63 showed a 78% and 85% reduction in the cortical and hippocampal amyloid load, respectively, reaffirming its potential to thwart the progression of Alzheimer's disease. IGC Pharma stated it hopes to progress TGR-63 into human trials.

ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains - Vimarsana News

ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains

Key Insights Given the large stake in the stock by institutions, ESSA Pharma's stock price might be vulnerable to their...

Source: yahoo.com
AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades' - Arch Capital Group (NASDAQ:ACGL), AbbVie (NYSE:ABBV) - Vimarsana News

AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades' - Arch Capital Group (NASDAQ:ACGL), AbbVie (NYSE:ABBV)

On CNBC’s "Halftime Report Final Trades," Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc.